| Similar Articles |
|---|
 |
Chemistry World
July 31, 2009
Matt Wilkinson |
Agilent swoops on Varian Agilent is buying rival analytical instrument maker Varian for $1.5 billion ( 900 million) - a move that will increase its market share in the bioanalysis arena and mark its entry into the nuclear magnetic resonance (NMR) market.   |
Chemistry World
October 23, 2014
Andy Extance |
Agilent to exit NMR US-headquartered instrument maker Agilent Technology has stopped taking orders for new nuclear magnetic resonance spectrometers, leaving many within the chemistry community with tough choices. |
Chemistry World
January 31, 2006
Katharine Sanderson |
Sharing Out the Lab Measurement Billions Pharmaceutical measurement company Agilent Technologies has updated over 40% of its high pressure liquid chromatography and mass spectrometry ranges, and introduced software that can be used on competitor's machines. |
Bio-IT World
October 2005
Robert M. Frederickson |
Nanoflow Enhances LC Devices New flow control systems save time while offering higher precision and sensitivity that are key to better comparative proteomic data coming out of liquid chromatography-mass spectronomy applications as well as more traditional clinical and diagnostic analyses. |
Chemistry World
March 27, 2013
Akshat Rathi |
Molecular cages to end crystallization nightmare X-ray crystallography has shaped modern chemistry. It is a powerful tool for molecular structural analysis. But it suffers from one big drawback: it can only analyze materials that form well-defined crystals. This may now be about to change. |
Bio-IT World
May 2006
Robert M. Frederickson |
A New (Bio)Spin on NMR Applications Bruker BioSpin recently announced several introductions to improve throughput, sensitivity, and versatility of its systems for nuclear magnetic resonance applications starting with the SampleJet, a robotics system for high-throughput transfers of NMR sample tubes into the NMR spectrometer. |
Chemistry World
July 24, 2013 |
Spectrometry for the masses A mass spectrometer ionizes chemical compounds to generate charged molecules or molecular fragments and allows the measurement of the molecular mass of a sample. Mass spectrometry continues to move forward, shaping new scientific fields in the process. |
Bio-IT World
October 14, 2004
Zachary Zimmerman |
Follow the Pathway to Increased ROI Although this software has been commercially available for only a year, Ingenuity claims nine of the top 10 pharmaceutical companies as customers, including Pfizer, Wyeth, GlaxoSmithKline, and Aventis. |
Chemistry World
March 25, 2010
Rebecca Trager |
Big pharma scores in US healthcare reform President Obama has signed the biggest US healthcare reform since the 1960s, and although it is largely seen as a victory for the pharmaceutical industry, some analysts are characterising it as a 'double-edged sword'. |
Chemistry World
December 2009 |
Column: In the pipeline Is the pharmaceutical industry churning out copycat versions of existing therapies? The author dispels a few myths about 'me-too' drugs |
The Motley Fool
February 25, 2004
Brian Gorman |
Merck's Slow and Steady The big pharma's cautious approach could pay off in the industry. |
Bio-IT World
April 15, 2003
Mark D. Uehling |
Target Elimination Industry and FDA scientists turn to databases, applications software, and laboratory chips to move the safest, most effective molecules into clinical trials. |
The Motley Fool
April 26, 2007
Brian Lawler |
Brazil's Boneheaded Drug Move Brazil already receives a steep discount on the price that Merck charges it for its HIV compounds. Nevertheless, it wants still lower prices to help reduce the government's costs associated with supplying drugs to those living with HIV/AIDS. |
Chemistry World
March 21, 2013
Neil Withers |
Harry Kroto: From light years to nanometers -- and back My emphasis in the Pittcon plenary lecture is that the discovery of C 60 started off from an interest in massive clouds of gas in interstellar space. You go from these huge objects into the nanoscale world and back again out into space. |
Chemistry World
July 29, 2013 |
The ABC of GCs How do you decide what gas chromatograph is right for your lab? Elisabeth Jeffries looks at what's on the market |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
Chemistry World
August 1, 2010
Mike Brown |
Snapshots of mystery molecular structures Researchers have used atomic force microscopy to produce clear molecular images that can help determine the correct atomic structure of unknown organic molecules. |
Chemistry World
May 30, 2014
Phillip Broadwith |
How good do you want it? In a chemical manufacturing environment, the most important questions for process chemists are qualitative: how shall we make this molecule? How can we do it safely? |
Reactive Reports
Issue 52
David Bradley |
Interview with Gary Martin With more than 35 years experience in NMR spectroscopy, Gary Martin reveals some of the insights he has gained in this field. |
The Motley Fool
March 15, 2004
W.D. Crotty |
60 Minutes on Drugs Will the weekly news magazine's prime-time slam rattle the drug stocks? |
The Motley Fool
March 3, 2009
Brian Orelli |
Stop Worrying About Follow-On Biologics They're inevitable, but they won't hurt biotech as much as you might think. |
Bio-IT World
August 2005
Johan Bostrom |
Agilent Acquisitions Bolster Portfolio of Products A string of acquisitions is helping Agilent Technologies establish itself as a major player in informatics for analytical laboratories, and its expanding product portfolio has made it a serious player in laboratory analysis automation and software integration. |
Chemistry World
June 2008
Sarah Houlton |
Breaking the rules The author finds out about some chemical tricks that can give a new drug the best possible odds of success |
Chemistry World
December 2007
Derek Lowe |
Column: In the Pipeline The challenge of biologics. |
Chemistry World
May 2006 |
New on the Market Spectrometer for field use... 3D nano movies... NMR cryoprobes... High optical throughput... Detecting nuclear threats... Sensing hazardous gases... LC/MS with ultra performance... etc. |
Chemistry World
February 24, 2014
Derek Lowe |
Tools of the trade Organic synthesis has always depended on instrumental analysis, even when the instruments were a thermometer for distillations and a melting point stage for crystals. |
Chemistry World
October 26, 2007
Richard Van Noorden |
Proton NMR Spots Shape-Shifting Tablets UK scientists have extended the bounds of solid-state NMR to quickly solve a problem plaguing the pharmaceutical industry: how to spot unwanted crystal packing forms in a drug tablet. |
Chemistry World
April 2006
Ian Shuttler |
Comment: The Analytical Business: Alive and Kicking? The evidence of the underlying health of the analytical business is shown by the continuous stream of new products and services that companies introduce. |
National Defense
June 2010
Grace V. Jean |
Research Challenge: How to Defend Against Still-Undefined Chemical, Biological Attacks Military scientists are often criticized for not working fast enough and for not pushing technologies into the field more expeditiously. Those working in chemical and biological sciences are no exception. |
The Motley Fool
August 16, 2011
Anders Bylund |
Boring Business, Exciting Results Measurement tools make for boring cocktail-party discussion, but there's an exciting investment opportunity brewing in this industry. Agilent's business now rests on a balanced set of growing legs. |
Chemistry World
March 21, 2013
Neil Withers |
Norman Dovichi: Singing the praises of the unsung hero At this year's Pittcon, Norman Dovichi of Notre Dame University in Indiana, US, received the 2012 Robert Boyle Prize for Analytical Science from the RSC. The prize is awarded for outstanding contributions to analytical science. |
Chemistry World
January 9, 2014 |
Spinning into focus NMR is used by big industry, and scientists in pharmaceutical companies, for example, have appreciated the benefits of NMR spectroscopy for years. It reveals the structure of molecules in a sample, providing more information than some other analytical techniques. |
Chemistry World
November 2007 |
New on the Market Miniature spectrometers... Two-in-one x-ray... Magnetic nano-tags for molecules... Flexible gas chromatograph... Fluorimetry... Benchtop crystallography... X-ray diffraction... Particles fully described... |
Chemistry World
December 2008 |
Column: In the pipeline I've worked on two drug discovery efforts (one right after the other, as fate would have it) whose final compounds differed by essentially one methyl group from the starting points of each project. |
The Motley Fool
February 22, 2011
Brian Orelli |
A Billion-Dollar Market to Open "Very Soon" Biosimilar drugs are finally coming to the U.S. |
Chemistry World
September 6, 2013
Melissae Fellet |
Unravelling stereochemistry via mass spectrometry Researchers have used mass spectrometry to determine the stereochemistry of a prototypical chiral molecule, CHBrClF. |
Bio-IT World
May 2006 |
News Blast Added Value... Biobanking... Acquisition... |
Chemistry World
February 14, 2012
Rebecca Trager |
FDA proposes biosimilars approval pathway The US Food and Drug Administration has released its long awaited guidance to assist in the development and approval of so-called 'biosimilars' - biological drugs that are very similar to licensed ones. |
The Motley Fool
March 18, 2004
Brian Gorman |
The Drug Cost Conundrum While drug prices continue to climb, the public and its representatives in government are demanding cheaper pharmaceuticals. The industry is not likely to find cover in Medicare biotechnology. Instead, investors should look for drug makers that are finding ways to operate leaner and meaner. |
The Motley Fool
February 15, 2011
Anders Bylund |
Testing, Testing: Agilent Loves Smartphones The testing equipment expert saw first-quarter communications orders rise by 45% year-over-year, driven by its customers needing test equipment for smartphones and tablets. |
Chemistry World
April 2007 |
New on the Market Gold award for MS waves... Detecting UV in miniature... MS for proteins and peptides... World's smallest FT-IR... etc. |
Reason
April 2001
Ronald Bailey |
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? |
Bio-IT World
July 14, 2004
Julia Boguslavsky |
Mass Spec Show and Tell The conference director for Cambridge Healthtech Institute offers highlights from the annual meeting of the American Society for Mass Spectrometry, particularly on mass spec and proteomics. |
Technology Research News
August 27, 2003 |
Light makes molecule shine Researchers from Kyushu University in Japan have constructed a fluorescent molecule that can be repeatedly switched on and off. If a way can be found to switch individual, closely-packed molecules on and off, fantastic amounts of information could be stored in very small spaces. |
Pharmaceutical Executive
June 1, 2009
John F. Kouten |
On the Right Pathways With staggering year-over-year growth, biosimilars are "the future of medicine." Marketers must position their companies for the inevitable changes. President Barack Obama has pledged support for legislation governing biosimilars. |
